MedPath

Outpatient autologous stem cell transplantatio

Phase 2
Conditions
Health supervision and care of foundling
Outpatient autologous stem cell transplantation.
Registration Number
IRCT138711081030N6
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
9
Inclusion Criteria

1- Acceptance of patient. 2- Patient is in a complete remission (CR1). 3- Performance score 80-100 or 0-2. 4- No heart, liver, kidneys or lungs dysfunction. 5- The distance from the patient’s home to the hospital should be no more than 60 minutes. 6- The existence of an educated care giver, with at least a diploma, who’s able to be with the patient twenty-four hours a day and seven days a week. 7- The patient should have suitable living conditions at home. 8 - The patient should not be heavily treated. Exclusion criteria: 1- Patients who don’t accept (to be out-patients). 2- Progressive or refractory disease. 3- A patient who has had several treatments before (heavily treated) 4- Creatinin >1.5 5- cardiac ejection fraction is less than %50 6- liver’s enzymes are twice as large as normal.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
WBC recovery. Timepoint: One month after transplantation. Method of measurement: Absolute Neutrophil Count = 0.5×10^9 /L.;Platelet recovery. Timepoint: One month after transplantation. Method of measurement: Platelet =20×10^9 /L.
Secondary Outcome Measures
NameTimeMethod
Early mortality. Timepoint: One year after transplantation. Method of measurement: Survival monitoring.
© Copyright 2025. All Rights Reserved by MedPath